Ross R Jennens (Ross Jennens)

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 3

Top Topics

Cerebrospinal Fluid

Tyrosine Kinase

Top Venues

JCO precision oncology

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Cancer research communications

This page only lists publications with an associated author ORCID identifier.

Publications

Jason D Lickliter, Jeremy Ruben, Ganessan Kichenadasse, Ross R Jennens, Cecelia Gzell, Ralph P Mason, Heling Zhou, Jennifer Becker, Evan C Unger, Baldassarre Stea
Dodecafluoropentane Emulsion as a Radiosensitizer in Glioblastoma Multiforme. Cancer research communications 3 (8) (2023)
Marina-Chiara Garassino, Shirish M Gadgeel, Giovanna Speranza, Enriqueta Felip Font, Emilio Esteban, Manuel Dómine, Maximilian J Hochmair, Steven Francis Powell, Helge G Bischoff, Nir Peled, Francesco Grossi, Ross R Jennens, Martin Reck, Rina Hui, Edward B Garon, Takayasu Kurata, Jhanelle E Gray, Paul Schwarzenberger, Erin Jensen, M Catherine Pietanza, Delvys Rodriguez Abreu
Pembrolizumab Plus Pemetrexed and Platinum in Nonsquamous Non-Small-Cell Lung Cancer: 5-Year Outcomes From the Phase 3 KEYNOTE-189 Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Luke S McLean, Wasek Faisal, Sagun Parakh, Steven C Kao, Craig R Lewis, Melvin T Chin, Mark Voskoboynik, Malinda J Itchins, Ross R Jennens, Adam R Broad, Tessa A Morris, Benjamin J Solomon
Standard-Dose Osimertinib in EGFR-Mutated Non-Small-Cell Lung Adenocarcinoma With Leptomeningeal Disease. JCO precision oncology 5 (2022)